NM Wulffraat

1.1k total citations
31 papers, 382 citations indexed

About

NM Wulffraat is a scholar working on Hematology, Rheumatology and Immunology. According to data from OpenAlex, NM Wulffraat has authored 31 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 9 papers in Rheumatology and 8 papers in Immunology. Recurrent topics in NM Wulffraat's work include Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (7 papers) and Immune Cell Function and Interaction (5 papers). NM Wulffraat is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (7 papers) and Immune Cell Function and Interaction (5 papers). NM Wulffraat collaborates with scholars based in Netherlands, Italy and United States. NM Wulffraat's co-authors include John A. Snowden, Rachael Hough, Gerben Sinnema, Sebastiaan J. Vastert, Frans B.L. Hogervorst, Laura van ‘t Veer, Maja Bulatović Ćalasan, Isabelle Meyts, Adilia Warris and Jeroen G. Noordzij and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Annals of the Rheumatic Diseases.

In The Last Decade

NM Wulffraat

30 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
NM Wulffraat Netherlands 10 193 88 88 81 72 31 382
Sandy Hong United States 8 290 1.5× 134 1.5× 59 0.7× 154 1.9× 124 1.7× 15 481
Yuichi Yamasaki Japan 8 243 1.3× 92 1.0× 75 0.9× 148 1.8× 94 1.3× 16 356
Rebecca Nicolai Italy 7 87 0.5× 41 0.5× 73 0.8× 64 0.8× 54 0.8× 26 224
Ilaria Maccora Italy 12 152 0.8× 23 0.3× 42 0.5× 62 0.8× 74 1.0× 58 387
Gordana Sušić Serbia 8 115 0.6× 73 0.8× 22 0.3× 88 1.1× 135 1.9× 17 353
Yuka Okura Japan 9 100 0.5× 39 0.4× 127 1.4× 96 1.2× 50 0.7× 34 316
Maria Ekelund Sweden 9 261 1.4× 128 1.5× 23 0.3× 101 1.2× 80 1.1× 11 406
Séverine Guillaume France 8 148 0.8× 62 0.7× 25 0.3× 161 2.0× 33 0.5× 11 387
Tai Ju Hwang South Korea 11 125 0.6× 19 0.2× 50 0.6× 73 0.9× 60 0.8× 67 399
Normi Brück Germany 10 184 1.0× 64 0.7× 33 0.4× 127 1.6× 109 1.5× 21 326

Countries citing papers authored by NM Wulffraat

Since Specialization
Citations

This map shows the geographic impact of NM Wulffraat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NM Wulffraat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NM Wulffraat more than expected).

Fields of papers citing papers by NM Wulffraat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NM Wulffraat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NM Wulffraat. The network helps show where NM Wulffraat may publish in the future.

Co-authorship network of co-authors of NM Wulffraat

This figure shows the co-authorship network connecting the top 25 collaborators of NM Wulffraat. A scholar is included among the top collaborators of NM Wulffraat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NM Wulffraat. NM Wulffraat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wulffraat, NM, et al.. (2014). Mesenchymal stromal cells for treatment of arthritis. Best Practice & Research Clinical Rheumatology. 28(4). 589–603. 17 indexed citations
2.
Ravelli, Angelo, Nicolino Ruperto, Pierre Quartier, et al.. (2014). Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset. Pediatric Rheumatology. 12(S1).
3.
Wulffraat, NM, Nicolino Ruperto, Yosef Uziel, et al.. (2014). Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients. Pediatric Rheumatology. 12(S1). 1 indexed citations
5.
Benedetti, Fabrizio De, Nicolino Ruperto, Alexei A. Grom, et al.. (2013). PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study. Pediatric Rheumatology. 11(S2). 1 indexed citations
7.
Vastert, Sebastiaan J., et al.. (2011). Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis. Pediatric Rheumatology. 9(S1). 1 indexed citations
8.
Jager, Wilco de, et al.. (2011). Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients. Pediatric Rheumatology. 9(S1). 3 indexed citations
9.
Otten, M.H., François Prince, R. ten Cate, et al.. (2010). Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?. Annals of the Rheumatic Diseases. 70(2). 337–340. 16 indexed citations
10.
Pasmans, Suzanne G.M.A., et al.. (2010). Bullous lesions in Henoch Schönlein Purpura as indication to start systemic prednisone. Acta Paediatrica. 99(5). 781–783. 15 indexed citations
11.
Noordzij, Jeroen G., NM Wulffraat, Ásgeir Haraldsson, et al.. (2009). Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Archives of Disease in Childhood. 94(6). 448–449. 52 indexed citations
12.
Pasmans, Suzanne G.M.A., et al.. (2009). GNAS-associated disorders of cutaneous ossification: Two different clinical presentations. Bone. 46(3). 868–872. 20 indexed citations
13.
Wulffraat, NM, et al.. (2008). Early effects of Anakinra in corticosteroid naïve SOJIA patients. Pediatric Rheumatology. 6(S1). 1 indexed citations
14.
García, Paula, Angelo Ravelli, Angela Pistorio, et al.. (2006). ANTINUCLEAR ANTIBODY POSITIVITY IS THE BEST PREDICTOR OF RESPONSE TO METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITIS. ANALYSIS OF THE PRINTO TRIAL. JCR Journal of Clinical Rheumatology. 12(Supplement). S12–S13. 1 indexed citations
15.
Hough, Rachael, John A. Snowden, & NM Wulffraat. (2005). Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. British Journal of Haematology. 128(4). 432–459. 52 indexed citations
16.
Cordonnier, C., Rodrigo Martino, Plı́nio Trabasso, et al.. (2004). Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients. Clinical Infectious Diseases. 38(9). 1229–1236. 56 indexed citations
17.
Wulffraat, NM. (1999). Haemopoietic stem-cell transplantation for juvenile chronic arthritis. The Lancet. 353(9167). 1885–1885. 2 indexed citations
18.
Wulffraat, NM, et al.. (1998). Atypical juvenile generalized scleroderma presenting as polyarthritis and failure to thrive. Lara D. Veeken. 37(2). 222–227. 3 indexed citations
19.
Wulffraat, NM, E. A. M. Sanders, C. A. P. Fijen, et al.. (1994). Deficiency of the β subunit of the eighth component of complement presenting as arthritis and exanthem. Arthritis & Rheumatism. 37(11). 1704–1706. 3 indexed citations
20.
Wulffraat, NM, et al.. (1991). [Erroneous diagnosis 'neonatal hypoglycemia' due to incorrect preservation of blood samples].. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 135(37). 1691–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026